Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Corporativo FraguaB de CVCGSBF 67 Cash-to-Debt is 1.72 as of Dec. 2024, which is 13% below its 10-year median of 1.98. GuruFocus rates CGSBF with a GF Score™ of 67/100. Among 673 Healthcare Providers & Services companies, Corporativo FraguaB de CV ranks better than 63.45% on this metric.
Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Corporativo FraguaB de CV's cash to debt ratio for the quarter that ended in Dec. 2024 was 1.72.
If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Corporativo FraguaB de CVcould pay off its debt using the cash in hand for the quarter that ended in Dec. 2024.
The historical rank and industry rank for Corporativo FraguaB de CV's Cash-to-Debt or its related term are showing as below:
CGSBF'
s Cash-to-Debt Range Over the Past 10 Years
Min: 1.02 Med: 1.98 Max: No Debt
Current: 1.72
During the past 13 years, Corporativo FraguaB de CV's highest Cash to Debt Ratio was No Debt. The lowest was 1.02. And the median was 1.98.
CGSBF's Cash-to-Debt is ranked better than 63.45% of 673
companies
in the Healthcare Providers & Services industry
Industry Median: 0.78
vs CGSBF: 1.72
Corporativo FraguaB de CV (OTCPK:CGSBF) Cash-to-Debt Explanation
If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.
Corporativo FraguaB de CV Cash-to-Debt Related Terms
Corporativo FraguaB de CV Cash-to-Debt Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
Corporativo FraguaB de CV Cash-to-Debt Competitor Comparison
For the Pharmaceutical Retailers subindustry, Corporativo FraguaB de CV's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Corporativo FraguaB de CV Cash-to-Debt vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Corporativo FraguaB de CV's Cash-to-Debt distribution charts can be found below:
* The bar in red indicates where Corporativo FraguaB de CV's Cash-to-Debt falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Corporativo FraguaB de CV (CGSBF) has a Cash-to-Debt of 1.72 as of Dec. 2024. This is 13% below median its historical median of 1.98. Over the past decade, Corporativo FraguaB de CV's Cash-to-Debt has ranged from 1.02 to 10,000.00. According to the industry distribution chart, Corporativo FraguaB de CV ranks #246 out of 673 companies in the Healthcare Providers & Services industry, placing it in the top 36.6%.
Is Corporativo FraguaB de CV's Cash-to-Debt too high?
Corporativo FraguaB de CV's current Cash-to-Debt of 1.72 is 13% below median its 10-year median of 1.98. Over the past 10 years, this metric has ranged from a low of 1.02 to a high of 10,000.00. The Healthcare Providers & Services industry median Cash-to-Debt is 0.78. Corporativo FraguaB de CV's value of 1.72 is 120.5% above this industry median. Based on the distribution chart, Corporativo FraguaB de CV ranks #246 out of 673 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Corporativo FraguaB de CV has a GF Score™ of 67/100, reflecting its overall financial health beyond just this single metric.
How does Corporativo FraguaB de CV's Cash-to-Debt compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Corporativo FraguaB de CV ranks #246 out of 673 companies for Cash-to-Debt. This puts Corporativo FraguaB de CV in the upper half of its industry. The industry median Cash-to-Debt is 0.78. Corporativo FraguaB de CV's value of 1.72 is 120.5% above this benchmark. Historically, Corporativo FraguaB de CV's own Cash-to-Debt has ranged from 1.02 to 10,000.00 over the past decade. While the company's 10-year median is 1.98 vs. the industry median of 0.78, Corporativo FraguaB de CV has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash-to-Debt for a Healthcare Providers & Services company?
The median Cash-to-Debt among Healthcare Providers & Services companies is 0.78, based on 673 companies in the industry. Companies in the top quartile (top 25%) have a Cash-to-Debt significantly above this median, while those in the bottom quartile fall well below. However, Cash-to-Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Corporativo FraguaB de CV's current Cash-to-Debt of 1.72 is 120.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash-to-Debt mean?
A high Cash-to-Debt can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median Cash-to-Debt is 0.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Corporativo FraguaB de CV's current Cash-to-Debt is 1.72, which is 13% below median its own 10-year median of 1.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Corporativo FraguaB de CV stock overvalued right now?
Corporativo FraguaB de CV (CGSBF) has a current Cash-to-Debt of 1.72. The current Cash-to-Debt is 1.72, which is 13% below median its 10-year median of 1.98 and 120.5% above the Healthcare Providers & Services industry median of 0.78. Corporativo FraguaB de CV's overall GF Score™ is 67/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash-to-Debt calculated?
Cash-to-Debt is calculated from a company's financial statements. For Corporativo FraguaB de CV (CGSBF), the current Cash-to-Debt is 1.72 as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Corporativo Fragua SAB de CV is engaged in the drug retail sector in Mexico. The company operates a network of pharmacies under the SuperFarmacia brand name, focusing on selling medicines, medical devices, and a variety of other products, including grocery items, exercise machines, perfumes, housewares, electronics, personal care products, toys, and photographic equipment.
67GF Score
Get the complete analysis for CGSBF
Cash-to-Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CGSBF has been successfully added to your 
